Your session is about to expire
← Back to Search
Behavioural Intervention
Educational Video for Childhood Cancer
N/A
Recruiting
Led By Suzanne MacFarland, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks after testing
Awards & highlights
Study Summary
This trial will test whether an informational video about paired tumor/normal testing is acceptable to children and adolescents with a new cancer diagnosis, and whether it is feasible to deliver.
Who is the study for?
This trial is for children and adolescents aged 12 or older with a new diagnosis of cancer, tumors, or genetic disorders. Participants must be able to understand and speak English fluently without cognitive impairments that limit comprehension. It's also open to parents/legal guardians of these patients at the Children's Hospital of Philadelphia.Check my eligibility
What is being tested?
The study is testing an educational video designed to inform about paired tumor/normal genetic testing in young patients with cancer or other related diagnoses. The goal is to assess how acceptable, feasible, and effective this video is as a resource.See study design
What are the potential side effects?
Since this trial involves an educational video rather than a medical treatment, there are no direct physical side effects associated with it. However, participants may experience emotional or psychological responses based on the content.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 4 weeks after testing
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks after testing
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Knowledge Score - Before Results
Secondary outcome measures
Acceptability of use of an informational video on paired tumor/normal testing for participants with a new cancer or other diagnosis
Feasibility of an informational video on paired tumor/normal testing for children and adolescents with a new cancer diagnosis.
Knowledge Score - After Results
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: With VideoExperimental Treatment1 Intervention
In year 2, we will recruit families of patients receiving the updated standard-of-care approach to tumor-normal genetic testing with provider based education and an educational video.
Group II: Without VideoActive Control1 Intervention
In year 1, we will recruit families of patients receiving the current standard-of-care approach to tumor-normal genetic testing with provider based education.
Find a Location
Who is running the clinical trial?
National Human Genome Research Institute (NHGRI)NIH
263 Previous Clinical Trials
283,776 Total Patients Enrolled
Children's Hospital of PhiladelphiaLead Sponsor
710 Previous Clinical Trials
8,588,552 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,715 Previous Clinical Trials
7,510,042 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not meet any of the requirements to be included in the study.You are available for screening within 1-4 weeks of genetic testing of your tumor and normal tissue.
Research Study Groups:
This trial has the following groups:- Group 1: With Video
- Group 2: Without Video
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many enrollees are being welcomed into this clinical research?
"Affirmative. The clinicaltrials.gov website confirms that this trial, which was first published on the 10th of September 2021, is actively recruiting applicants. 266 people are expected to join from one site."
Answered by AI
Is this investigation actively soliciting participants?
"Clinicaltrials.gov informs that this clinical trial is actively recruiting patients, and has been since September 10th 2021 with the latest update occurring on July 21st 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger